FDG-PET/MR

DEVICE2 trials

Sponsors

Washington University School of Medicine

Conditions

Cervical CancerTriple Negative Breast NeoplasmsUterine Cervical CancerUterine Cervical Neoplasms

Phase 1

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

TerminatedNCT02317302

Washington University School of MedicineCervical Cancer, Uterine Cervical Cancer, Uterine Cervical Neoplasms

Start: 2011-06-28End: 2020-06-02Updated: 2020-06-11

Phase 2

Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity

TerminatedNCT02124902

Washington University School of MedicineTriple Negative Breast Neoplasms

Start: 2014-07-07End: 2021-12-31Updated: 2022-11-07

Related Papers

Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer

Clinical Cancer Research2025-03-202 citations

Abstract 2420: Evaluating circulating tumor DNA (ctDNA) as a prognostic biomarker utilizing a tissue-free epigenomic assay in early-stage triple negative breast cancer (TNBC)

Cancer Research2024-03-22

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.

2021-06-2631 citations

Abstract P2-16-03: Neoadjuvant treatment of triple negative breast cancer patients with docetaxel and carboplatin to assess anti-tumor activity

Cancer Research2020-02-15

Abstract P2-02-14: Circulating tumor DNA predicts clinical outcome in early stage triple negative breast cancer

Cancer Research2018-02-15

Abstract P1-07-11: Tumor genomic profiling of triple negative breast cancer during neoadjuvant chemotherapy: Results from a prospective trial of carboplatin and docetaxel

Cancer Research2017-02-15

A co-clinical phase II trial of carboplatin and docetaxel as neoadjuvant treatment for triple negative breast cancer with genomic discovery analysis.

Journal of Clinical Oncology2016-05-201 citations